A Retrospective Cohort Study: Influence of MTHFR C677T and A1298C Polymorphisms on the Survival of Pediatric Patients With Non-Hodgkin's Lymphoma

Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma

NCT02396043 ·Status: UNKNOWN ·Phase: PHASE2

Lenalidomide Combined With R-CHOP(R2-CHOP) in Newly Diagnosed Double-expressor Diffuse Large B-Cell Lymphoma Patients

NCT04164368 ·Status: COMPLETED ·Phase: PHASE2

A Trial to Compare Ibrutinib Versus Lenalidomide in Combination With MRE-chemotherapy for Adult Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL)

NCT04129710 ·Status: RECRUITING ·Phase: PHASE2

Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas

NCT00001237 ·Status: COMPLETED ·Phase: PHASE2

A Study of RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

NCT05444322 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Follicular Lymphoma in Real World Study

NCT05846763 ·Status: RECRUITING

Lenalidomide Plus R-CHOP for CNS Relapse Prophylaxis in Diffuse Large B-cell Lymphoma

NCT04544059 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

NCT04922567 ·Status: RECRUITING ·Phase: PHASE2

High-dose Intravenous Methotrexate Versus Intrathecal Methotrexate for Central Nervous System Prophylaxis in DLBCL

NCT03123718 ·Status: UNKNOWN ·Phase: PHASE3

The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter Study

NCT06656234 ·Status: NOT_YET_RECRUITING

Polatuzumab Vedotin in Patients With Relapsed and Refractory Diffuse Large B Cell Lymphoma

NCT05006534 ·Status: COMPLETED

Rituximab Plus Methotrexate With or Without Lenalidomide in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

NCT04481815 ·Status: RECRUITING ·Phase: PHASE2

A Phase I/II Study of Diffuse Large B-cell Lymphoma

NCT04856137 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Abscopal Effect of Radiotherapy in Combination With rhGM-CSF for Advanced Thymic Epithelial Tumours

NCT05407649 ·Status: UNKNOWN ·Phase: PHASE2

A Multicenter, Retrospective Observational Study to Evaluate the Effectiveness and Safety of Polatuzumab Vedotin

NCT04624893 ·Status: UNKNOWN

CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma

NCT01746992 ·Status: UNKNOWN ·Phase: PHASE4

Cell Free DNA in Mature B-cell Lymphoma

NCT04088422 ·Status: RECRUITING

Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma

NCT05182957 ·Status: RECRUITING ·Phase: PHASE2

A Retrospective Study on Extranodal DLBCL

NCT06549361 ·Status: COMPLETED

A Study of Efficacy and Safety of Glofitamab in Combination With Salvage Therapy in a Real-world Setting in Chinese Adult Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.

NCT06497452 ·Status: RECRUITING

Rituximab Maintenance Treatment of Newly Diagnosed Follicular Lymphoma After BR or RCHOP or R2: a Multicenter Clinical Study

NCT04842318 ·Status: UNKNOWN ·Phase: PHASE4

A Study of LP-168 in Participants With Relapse or Refractory B-Cell Lymphoma

NCT04993690 ·Status: RECRUITING ·Phase: PHASE1

Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection

NCT06541327 ·Status: RECRUITING

A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma

NCT07189065 ·Status: RECRUITING ·Phase: PHASE2

GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma

NCT00896519 ·Status: UNKNOWN ·Phase: PHASE2